Breaking News, Promotions & Moves

Agilent Names New CEO

McMullen succeeds Sullivan

By: Kristin Brooks

Managing Editor, Contract Pharma

Mike McMullen has been appointed chief executive officer of Agilent Technologies Inc., effective immediately. Mr. McMullen succeeds William (Bill) Sullivan, who becomes a company advisor until he retires on Oct. 31, 2015.
 
“Bill Sullivan has been an extraordinary CEO over the past decade,” said James G. Cullen, chairman of Agilent’s board of directors. “Under his leadership, the company has been transformed from a diversified technology company to a highly focused leader in life sciences, diagnostics and applied markets.”
 
Mr. McMullen is Agilent’s third president and CEO since the company spun off from Hewlett-Packard Co. in 1999. He has more than 30 years of experience with Agilent and Hewlett-Packard and has served as president and chief operating officer since September 2014.
 
He has been responsible for overseeing the company’s three businesses (Life Sciences and Applied Markets Group, Agilent CrossLab Group, and Diagnostics and Genomics Group); Order Fulfillment; and the global organization that houses IT, workplace services, global sourcing and logistics.
 
McMullen joined Hewlett-Packard Co. in 1984 as a financial analyst in the Analytical Products Group. Since then he has served in various senior management positions. 
 
“Mike McMullen has already created strong momentum in taking the company forward,” Cullen said. “Since being named CEO-elect six months ago, he has built a new organizational structure and created compelling strategies that will create growth and value for our shareholders.”
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters